Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNTARA LIMITED Director's Dealing 2008

Aug 26, 2008

65830_rns_2008-08-26_cad3dd22-6d71-487b-a33a-9c85c7b38027.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity PHARMAXIS LTD

ABN 75 082 811 630

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director William Delaat
Date of last notice 24 June 2008

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Change in indirect interest
Nature of indirect interest Shares acquired by Mr William Delaat with his
(including registered holder) spouse as joint trustees of a superannuation fund
Note: Provide details of the circumstances giving rise to the relevantinterest. of which Mr Delaat is a member and a beneficiary
Date of change 26 August 2008
No. of securities held prior to change Nil
Class Ordinary shares
Number acquired 25,000
Number disposed Nil
Value/Consideration $1.973001 per share
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change 25,000
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation
Interest after change
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002